DHI Group

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

Earnings

News

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

ATOM

AZPN

FDMT

HELE

UCAR

U.S. stocks traded higher this morning, with the Dow Jones gaining around 100 points on Thursday.

Following the market opening Thursday, the Dow traded up 0.38% to 33,429.66 while the NASDAQ rose 0.88% to 11,958.77. The S&amp;P 500, also rose, gaining, 0.61% to 4,080.56.

Dow Surges 100 Points; Meta Platforms Reports Upbeat Results

Pre-Market Outlook

Movers

Trading Ideas

AINC

ALNA

AMPE

AMST

AMTD

APDN

AREB

ARIS

ATTO

ATUS

BALL

BCRX

BNTC

CCXI

CNET

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

COIN

CROX

CUEN

DBGI

ECPG

ECVT

EGHT

ELOX

ENVB

FRGE

FSLY

FTNT

GOVX

GRNA

GRNQ

HSCS

HSDT

IMUX

INFU

INSM

ITRI

KSPN

LCID

LEGH

LFLY

LQDT

LXEH

MDIA

MELI

MHUA

MSPR

NERV

NNVC

NVIV

PAGS

PGEN

PRFT

QNRX

RCII

RVLV

SITM

SOPA

STAF

SYRS

TMBR

TNDM

TTMI

UFCS

USPH

VAPO

Gainers


	ChemoCentryx, Inc.  (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash.


Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday

ADTH

AERC

AGLE

AKUS

ANGN

ANNX

ANTX

AUVI

AVTX

AXDX

BAOS

BCEL

BMEA

BOXD

BSGM

CBAY

CDAK

CIFR

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

CPTN

CRDF

CTSO

DCTH

DRRX

DRTS

EFOI

ENSV

EVEX

FIXX

GLOP

GTLB

HILS

HLBZ

HUSA

INKT

KRBP

LMDX

MCRB

METC

The Marygold Companies, Inc. Common Stock

MGLD

MGTA

MLTX

MRTX

NINE

NVFY

OMGA

ONCR

ORIC

PIII

PMVP

PPSI

PRTG

PSTX

QUBT

RDBX

REVG

RKLY

SIOX

SNCE

SNSE

SRRK

STRC

STTK

TRKA

TUYA

URGN

UTSI

VERU

VIRX

WEJO

Gainers


	AeroClean Technologies, Inc. (NASDAQ: AERC) gained 154.7% to settle at $12.10 on Tuesday on continued strength after the FDA granted clearance for the company&#39;s pūrgo technology, classifying it as a class II medical device.


79 Biggest Movers From Yesterday

DHI Group Inc

<p>Barrington Research  analyst Gary Prestopino   maintains DHI Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) with a Outperform and maintains $7 price target.</p>


Price Target

Analyst Ratings

Barrington Research Maintains Outperform on DHI Group, Maintains $7 Price Target

<p><strong>DHI Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) announced its Q4 earnings on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a breakdown of the earnings report.</p>
<h3>Earnings</h3>
<p>DHI Group beat estimated earnings by 0.07%, reporting an EPS of $0.07 versus an estimate of $0.0.</p>
<p>Revenue was down $2.50 million from the same period last year.</p>
<h3>Overview of Past Earnings</h3>
<p>During the previous quarter, the company beat on EPS by $0.02, leading to a 7.000000000000001% drop share price change the next day.</p>
<p>Here's a look at DHI Group's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.03</td>
<td>0.03</td>
<td>0.02</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.05</td>
<td>0.06</td>
<td>0.05</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>35.27M</td>
<td>36.09M</td>
<td>36.36M</td>
<td>35.79M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>35.28M</td>
<td>35.83M</td>
<td>36.02M</td>
<td>37.29M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for DHI Group <a href="https://www.benzinga.com/quote/DHX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Insights into DHI Group Q4 Earnings

<p>The Q4 earnings report for <strong>DHI Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) was released on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the latest announcement.</p>
<h3>Earnings</h3>
<p>DHI Group beat estimated earnings by 0.07%, reporting an EPS of $0.07 versus an estimate of $0.0.</p>
<p>Revenue was down $2.50 million from the same period last year.</p>
<h3>Previous Earnings Records</h3>
<p>Last quarter the company beat on EPS by $0.02 which was followed by a 7.000000000000001% drop in the share price the next day.</p>
<p>Here's a look at DHI Group's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.03</td>
<td>0.03</td>
<td>0.02</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.05</td>
<td>0.06</td>
<td>0.05</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>35.27M</td>
<td>36.09M</td>
<td>36.36M</td>
<td>35.79M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>35.28M</td>
<td>35.83M</td>
<td>36.02M</td>
<td>37.29M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for DHI Group <a href="https://www.benzinga.com/quote/DHX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


DHI Group Q4 Earnings Report: What Investors Need to Know

<p>The earnings results for <strong>DHI Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) for Q4 were made public on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a comprehensive overview of the announcement.</p>
<h3>Earnings</h3>
<p>DHI Group beat estimated earnings by 0.07%, reporting an EPS of $0.07 versus an estimate of $0.0.</p>
<p>Revenue was down $2.50 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>Last quarter the company beat on EPS by $0.02 which was followed by a 7.000000000000001% drop in the share price the next day.</p>
<p>Here's a look at DHI Group's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.03</td>
<td>0.03</td>
<td>0.02</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.05</td>
<td>0.06</td>
<td>0.05</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>35.27M</td>
<td>36.09M</td>
<td>36.36M</td>
<td>35.79M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>35.28M</td>
<td>35.83M</td>
<td>36.02M</td>
<td>37.29M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for DHI Group <a href="https://www.benzinga.com/quote/DHX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


DHI Group Earnings Report: Q4 Overview

<p><strong>DHI Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) just disclosed its Q4 earnings on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's a brief overview of the earnings report.</p>
<h3>Earnings</h3>
<p>DHI Group beat estimated earnings by 0.07%, reporting an EPS of $0.07 versus an estimate of $0.0.</p>
<p>Revenue was down $2.50 million from the same period last year.</p>
<h3>Historical Earnings Summary</h3>
<p>In the previous quarter, the company beat on EPS by $0.02, resulting in a 7.000000000000001% drop change in the share price the following day.</p>
<p>Here's a look at DHI Group's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.03</td>
<td>0.03</td>
<td>0.02</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.05</td>
<td>0.06</td>
<td>0.05</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>35.27M</td>
<td>36.09M</td>
<td>36.36M</td>
<td>35.79M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>35.28M</td>
<td>35.83M</td>
<td>36.02M</td>
<td>37.29M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for DHI Group <a href="https://www.benzinga.com/quote/DHX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


DHI Group Q4 Earnings Summary & Key Takeaways

<p>DHI Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) sees FY2025 sales of $131.000 million-135.000 million vs $135.25 million estimate.</p>


Guidance

DHI Group Sees FY2025 Sales $131.000M-135.000M vs $135.25M Est

<p>DHI Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) sees Q1 sales of $32.000 million-33.000 million vs $33.62 million estimate.</p>


DHI Group Sees Q1 Sales $32.000M-33.000M vs $33.62M Est

<p><strong>DHI Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) reported its Q4 earnings results on Wednesday, February 5, 2025 at 04:15 PM.</p>
<p>Here's what investors need to know about the announcement.</p>
<h3>Earnings</h3>
<p>DHI Group beat estimated earnings by 0.07%, reporting an EPS of $0.07 versus an estimate of $0.0.</p>
<p>Revenue was down $2.50 million from the same period last year.</p>
<h3>Analysis of Past Earnings</h3>
<p>The company beat on EPS by $0.02 in the last quarter, resulting in a 7.000000000000001% drop share price change the following day.</p>
<p>Here's a look at DHI Group's past performance:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
<th><strong>Q4 2023</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.03</td>
<td>0.03</td>
<td>0.02</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.05</td>
<td>0.06</td>
<td>0.05</td>
<td>0.04</td>
</tr>
<tr>
<td><strong>Revenue Estimate</strong></td>
<td>35.27M</td>
<td>36.09M</td>
<td>36.36M</td>
<td>35.79M</td>
</tr>
<tr>
<td><strong>Revenue Actual</strong></td>
<td>35.28M</td>
<td>35.83M</td>
<td>36.02M</td>
<td>37.29M</td>
</tr>
</tbody>
</table>
</p>
<p>To track all earnings releases for DHI Group <a href="https://www.benzinga.com/quote/DHX/earnings">visit their earnings calendar here.</a> </p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Earnings Breakdown: DHI Group Q4

<p>DHI Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.02 by 250 percent. This is a 12.5 percent decrease over earnings of $0.08 per share from the same period last year.  The company reported quarterly sales of $34.78 million which beat the analyst consensus estimate of $34.29 million by 1.45 percent.  This is a 6.71 percent decrease over sales of $37.29 million the same period last year.</p>


Earnings Beats

DHI Group Q4 Adj EPS $0.07 Beats $0.02 Estimate, Sales $34.78M Beat $34.29M Estimate

Comments

DHI Group

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga